tiprankstipranks
Trending News
More News >
Neurocrine (NBIX)
NASDAQ:NBIX
US Market

Neurocrine (NBIX) Income Statement

Compare
1,529 Followers

Neurocrine Income Statement

Last quarter (Q3 2025), Neurocrine's total revenue was $794.90M, an increase of 27.78% from the same quarter last year. In Q3, Neurocrine's net income was $209.50M. See Neurocrine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.36B$ 1.89B$ 1.49B$ 1.13B$ 1.05B
Gross Profit
$ 2.32B$ 1.85B$ 1.47B$ 1.12B$ 1.04B
Operating Expenses
$ 1.75B$ 1.60B$ 1.22B$ 1.02B$ 872.80M
Depreciation and Amortization
$ 27.10M$ 21.30M$ 15.60M$ 10.90M$ 8.60M
EBITDA
$ 639.70M$ 416.10M$ 264.60M$ 138.10M$ 148.10M
Operating Income
$ 570.50M$ 250.90M$ 249.00M$ 102.50M$ 163.00M
Other Income/Expenses
$ -84.50M$ 81.20M$ -35.10M$ -1.10M$ -56.30M
Pretax Income
$ 486.00M$ 332.10M$ 213.90M$ 101.40M$ 106.70M
Net Income
$ 341.30M$ 249.70M$ 154.50M$ 89.60M$ 407.30M
Per Share Metrics
Basic EPS
$ 3.40$ 2.56$ 1.61$ 0.95$ 4.37
Diluted EPS
$ 3.29$ 2.47$ 1.56$ 0.92$ 4.16
Weighted Average Shares Outstanding
100.40M 97.70M 95.80M 94.60M 93.10M
Weighted Average Shares Outstanding (Diluted)
103.70M 101.00M 98.90M 97.90M 97.80M
Currency in USD

Neurocrine Earnings and Revenue History